NeuClone Announces Preclinical Results for Stelara® (ustekinumab) Biosimilar Candidate
SYDNEY, May 10, 2018 /PRNewswire/ — Biopharmaceutical company NeuClone has announced positive preclinical results of its biosimilar to Johnson & Johnson’s Stelara®, including 3-dimensional (3-D) structure confirmation through X-ray crystallography…